Please login to the form below

Not currently logged in
Email:
Password:

allergy

This page shows the latest allergy news and features for those working in and with pharma, biotech and healthcare.

Takeda gets FDA fast-track status for Zika vaccine

Takeda gets FDA fast-track status for Zika vaccine

Meanwhile, the National Institute of Allergy and Infectious Diseases (NIAID) in the US reported positive phase I results for a pair of DNA vaccine candidates in The Lancet last month, and

Latest news

More from news
Approximately 11 fully matching, plus 191 partially matching documents found.

Latest Intelligence

  • Asthma: beyond the blue and the brown Asthma: beyond the blue and the brown

    for prevention of cat and ragweed allergies.

  • Deal Watch July 2016 Deal Watch July 2016

    And Finally, Reality Bites. ALK-Abello has issued a press release announcing that Merck &Co has walked away from the deal agreed in 2007 (with Schering-Plough) for the allergy treatments ... Grastek and Ragwitek are sublingual allergy immunotherapy (SLIT)

  • Allergies and asthma Allergies and asthma

    Allergies and asthma. Reframing the conversation from disease burden to prevention and health promotion. ... The safest way to manage allergy symptoms is to tackle them before they set in.

  • Coming to an understanding Coming to an understanding

    We derived greater insight and intelligence.”. A similar process on the composition of an allergy panel for product testing had the physicians working in groups to devise their 'panel of the

  • Deal Watch February 2016 Deal Watch February 2016

    Annapurna brings a portfolio of four AAV-based gene therapy programmes at the preclinical stage for alpha-1 antitrypsin deficiency, hereditary angioedema, cardiomyopathy associated with Friedreich's ataxia and severe allergy.

More from intelligence
Approximately 1 fully matching, plus 16 partially matching documents found.

Latest appointments

  • ALK-Abello appoints Søren Jelert as CFO ALK-Abello appoints Søren Jelert as CFO

    Dansih allergy immunotherapy company ALK-Abello has appointed Søren Jelert as its new chief financial officer, a role that sees him succeed Flemming Pederson at the pharmaceutical company. ... to become a truly global allergy company.”.

  • Cytovation expands management team Cytovation expands management team

    Grego is currently chief executive officer of Spire Bioventures, a global healthcare consultancy and mentoring service, and has previously held a number of management positions at Spanish allergy specialist Laboratorios LETI.

  • Lars Dreiøe joins Sobi in senior quality and compliance role Lars Dreiøe joins Sobi in senior quality and compliance role

    He will join the firm in January from Danish allergy vaccine company ALK Abelló, where he was international head of quality.

  • ARC names chairman and member of the board ARC names chairman and member of the board

    ARC is a privately held biopharma company developing desensitisation treatments for food allergies. ... Iwicki said: “ ARC is working to address a very compelling therapeutic area and provide an option to those dealing with food allergies.

  • Insmed appoints FDA's Dr Eugene Sullivan Insmed appoints FDA's Dr Eugene Sullivan

    He also spent a seven-year spell from 1999 at the FDA, where he held several positions, including deputy director of its Pulmonary and Allergy Products division.

More from appointments
Approximately 0 fully matching, plus 14 partially matching documents found.

Latest from PMHub

  • Allergies – Always a story

    It also ties in nicely with  Allergy Awareness Week, which runs from 20-26th April, run by Allergy UK. ... The number of stories around allergy will undoubtedly increase with this awareness raising week.

  • Artificial Intelligence: the new healthcare algorithm

    Crucially, this can result in improved patient outcomes and even the possibility of using an individual patient’ s history - such as previous illnesses, allergies or even  genetic makeup - to predict their

  • Double Communiqué award win for 90TEN

    90TEN and IPG created the Wheals of Despair programme, which took the real-life stories of people living with CSU alongside insights from Allergy UK and health professionals to create a

  • What does programmatic advertising mean for your pharma marketing strategy?

    These adverts have been used in the key disease areas of cancer, allergies, dermatology, smoking cessation, and dental care, with pharmaceutical companies, hospital systems, medical devices, clinical trial and insurance companies

  • Allergies – Always a story

    It also ties in nicely with  Allergy Awareness Week, which runs from 20-26th April, run by Allergy UK. ... The number of stories around allergy will undoubtedly increase with this awareness raising week.

More from PMHub
Approximately 3 fully matching, plus 9 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
wethepeople

wethepeople are bringing human appeal back to brand communications. Our approach allows us to create strategies, ideas and experiences that...

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...

Infographics